Clinical Trial Update: Vaccine Therapy in Curative Resected Prostate Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update investigating a vaccine therapy in curatively resected prostate cancer patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Oslo University Hospital | Conditions: Prostate Cancer | Phase 1, Phase 2 | Status: UNKNOWN